financetom
Business
financetom
/
Business
/
Carlyle-backed Rigaku raises $863 mln in Tokyo IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Carlyle-backed Rigaku raises $863 mln in Tokyo IPO
Oct 17, 2024 2:10 PM

TOKYO, Oct 17 (Reuters) - Rigaku Holdings

raised 129 billion yen ($863 million) after the Japan X-ray

testing tool maker priced its IPO at the top of its range,

according to a regulatory filing on Thursday.

The company, which is backed by buyout firm Carlyle

Group ( CG ), priced the IPO at 1,260 yen per share, at the top

end of the 1,230 to 1,260 yen range.

Rigaku will debut on the Tokyo Stock Exchange on Oct.

25.

On Tuesday Tokyo Metro raised 348.6 billion yen after

pricing its IPO, the largest in Japan for six years, at the top

of the range.

The IPO was more than 15 times oversubscribed, Reuters

reported, with investors attracted by the subway operator's

dividend yield.

Bain Capital

scrapped a plan

for an IPO of chipmaker Kioxia this month after investors

pushed for a lower valuation than the buyout firm was targeting,

Reuters has reported.

($1 = 149.5000 yen)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Summit Therapeutics Insider Bought Shares Worth $5,984,756, According to a Recent SEC Filing
Summit Therapeutics Insider Bought Shares Worth $5,984,756, According to a Recent SEC Filing
Sep 12, 2025
03:27 AM EDT, 09/12/2025 (MT Newswires) -- Mahkam Zanganeh, 10% Owner, Director, Co-Chief Executive Officer, on September 10, 2025, executed a purchase for 338,394 shares in Summit Therapeutics ( SMMT ) for $5,984,756. Following the Form 4 filing with the SEC, Zanganeh has control over a total of 591,831,532 common shares of the company, with 31,000 shares held directly and...
Lazard Insider Sold Shares Worth $4,240,260, According to a Recent SEC Filing
Lazard Insider Sold Shares Worth $4,240,260, According to a Recent SEC Filing
Sep 12, 2025
03:29 AM EDT, 09/12/2025 (MT Newswires) -- Evan L Russo, Chief Executive Officer of Asset Management, on September 09, 2025, sold 75,000 shares in Lazard ( LAZ ) for $4,240,260. Following the Form 4 filing with the SEC, Russo has control over a total of 227,915 common shares of the company, with 227,915 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1311370/000171748925000003/xslF345X05/wk-form4_1757633247.xml ...
United Therapeutics Insider Sold Shares Worth $3,183,777, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $3,183,777, According to a Recent SEC Filing
Sep 12, 2025
03:25 AM EDT, 09/12/2025 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & Chief Executive Officer, on September 10, 2025, sold 8,000 shares in United Therapeutics ( UTHR ) for $3,183,777. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 644,489 common shares of the company, with 130 shares held directly and 644,359 controlled...
Summit Therapeutics Insider Bought Shares Worth $5,984,756, According to a Recent SEC Filing
Summit Therapeutics Insider Bought Shares Worth $5,984,756, According to a Recent SEC Filing
Sep 12, 2025
03:28 AM EDT, 09/12/2025 (MT Newswires) -- Robert W Duggan, 10% Owner, Director, Co-Chief Executive Officer, on September 10, 2025, executed a purchase for 338,394 shares in Summit Therapeutics ( SMMT ) for $5,984,756. Following the Form 4 filing with the SEC, Duggan has control over a total of 591,831,532 common shares of the company, with 556,093,090 shares held directly...
Copyright 2023-2026 - www.financetom.com All Rights Reserved